Telefonica Enters Brazil's mHealth Market

By Admin
Share
Telefonica Digital has acquired a controlling stake in major Brazilian healthcare provider Axismed, in a bid to move into Brazils mobile health sector...

 

Telefonica Digital has acquired a controlling stake in major Brazilian healthcare provider Axismed, in a bid to move into Brazil’s mobile health sector. The exact percentage of the stake or the price paid has not yet been revealed.

Axismed is a prominent chronic care management firm in Brazil. The market for mobile health products is burgeoning, and while initially Telefonica will target corporate clients, it has plans to eventually extend services to subscribers of its mobile operator, Vivo.

Read Related Articles On Healthcare Global

The deal will allow the 180,000 patients currently in Axismed’s care to be contacted through a variety of different technologies, including videoconferencing, SMS, internet and mobile apps. Axismed aims to be able to receive medical information from patients via their domestic devices within one year.

If this goal is achieved, the firms will look to extending their footprint in Latin America, notably Chile that has been earmarked as a potential hotbed for mHealth services. In addition, Telefonica plans on offering its Vivo subscribers access to mHealth.

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma